Glessner Coleen
EVP, Quality & Ethics, and CPL
Glessner Coleen has filed 6 SEC Form 4 filings (7 transaction rows) across 1 company, with disclosures dating back to 2025. 6 of those filings fall inside the rolling window. Most recent filing: Jun 10, 2026.
On the most recent filing, Glessner Coleen is listed as EVP, Quality & Ethics, and CPL at Emergent BioSolutions Inc. Inside the rolling window, Glessner Coleen reported no open-market purchases and 1 open-market sale totaling $306K in EBS.
Companies traded
Other insiders at EBS
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$306K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Glessner Coleen made?
Glessner Coleen has filed 6 SEC Form 4 filings (7 transaction rows) across 1 company since 2025.
Which companies does Glessner Coleen trade?
Glessner Coleen has filed SEC Form 4 disclosures for 1 company, including EBS.
When was Glessner Coleen's most recent SEC Form 4 filing?
Glessner Coleen's most recent SEC Form 4 filing on Tracefour is dated Jun 10, 2026.
What is Glessner Coleen's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Glessner Coleen is listed as EVP, Quality & Ethics, and CPL.
What is Glessner Coleen's total buy and sell value in the current window?
Inside the rolling retention window, Glessner Coleen bought $0 and sold $306K based on SEC Form 4 filings.
What was Glessner Coleen's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 30,608 EBS shares on 2025-10-07, worth $306K, per SEC Form 4 filings.